Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state
of end-organ hypoperfusion that is frequently associated with multisystem organ failure. …

Over the past few decades, advances in pharmacological, catheter-based, and surgical
reperfusion have improved outcomes for patients with acute myocardial infarctions. However, …

Background The outcome of cardiogenic shock complicating myocardial infarction has not
appreciably changed in the last 30 years despite the development of various percutaneous …

Since its development and release in 2019, the Society for Cardiovascular Angiography and
Interventions (SCAI) shock stage classification for adult patients has been widely cited and …

Aim The “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients
With Chronic Coronary Disease” provides an update to and consolidates new evidence …

Background : A new 5-stage cardiogenic shock (CS) classification scheme was recently
proposed by the Society for Cardiovascular Angiography and Intervention (SCAI) for the …

Background Levosimendan is an inotropic agent that has been shown in small studies to
prevent or treat the low cardiac output syndrome after cardiac surgery. Methods In a multicenter…

Background Clinical investigations of shock in cardiac intensive care units (CICUs) have
primarily focused on acute myocardial infarction (AMI) complicated by cardiogenic shock (…

Background— Although previous studies have shown marked variation in out-of-hospital
cardiac arrest survival across US regions, factors underlying this survival variation remain …

Background— The postoperative risks for patients with coronary artery disease (CAD)
undergoing noncardiac surgery are well described. However, the risks of noncardiac surgery in …